secwatch / observer
8-K filed May 16, 2025, 7:59 PM ET ticker CORZ CIK 0001839341
leadership confidence high sentiment neutral materiality 0.35

Core Scientific appoints Elizabeth Crain to board; Jordan Levy elected chairman

Core Scientific, Inc./tx

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Elizabeth Crain

Director
CORZ · Core Scientific, Inc./tx
Effective
2025-05-14
Filed
May 16, 2025, 7:59 PM ET
On May 14, 2025, the Board appointed Elizabeth Crain as a member of the Board and the Chair of the Audit Committee of the Board, effective immediately.
Departed

Todd Becker

Director
CORZ · Core Scientific, Inc./tx
Effective
2025-05-13
Filed
May 16, 2025, 7:59 PM ET
On May 13, 2025, Todd Becker informed the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) of his resignation as a member of the Board and the applicable committees thereof, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Elizabeth Crain was appointed as Director at Core Scientific, Inc./tx.

Action
appointed
Role
Director
Exact text from the filing
On May 14, 2025, the Board appointed Elizabeth Crain as a member of the Board and the Chair of the Audit Committee of the Board, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Todd Becker resigned as Director at Core Scientific, Inc./tx.

Action
resigned
Role
Director
Exact text from the filing
On May 13, 2025, Todd Becker informed the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) of his resignation as a member of the Board and the applicable committees thereof, effective immediately.
View on SEC.gov

Core Scientific, Inc./tx filing history →

Source: SEC EDGAR
accession 0001628280-25-026294
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.